哪些是合理可预见的风险？ - Suppr

Suppr

超能文献

What are reasonably foreseeable risks?

作者信息

Resnik David B

机构信息

a National Institute for Environmental Health Sciences.

出版信息

Am J Bioeth. 2013;13(12):29-30. doi: 10.1080/15265161.2013.849304.

DOI:10.1080/15265161.2013.849304

PMID:24256530

Abstract

摘要

相似文献

What are reasonably foreseeable risks?

Am J Bioeth. 2013;13(12):29-30. doi: 10.1080/15265161.2013.849304.

The weird divergence of ethics and regulation with regard to informed consent.

Am J Bioeth. 2013;13(12):31-3. doi: 10.1080/15265161.2013.849308.

Randomization should be disclosed to potential research subjects.

Am J Bioeth. 2013;13(12):35-7. doi: 10.1080/15265161.2013.849307.

Risk, respect for persons, and informed consent in comparative effectiveness research.

Am J Bioeth. 2013;13(12):46-8. doi: 10.1080/15265161.2013.851299.

The "research misconception" and the SUPPORT trial: toward evidence-based consensus.

Am J Bioeth. 2013;13(12):48-50. doi: 10.1080/15265161.2013.851297.

Ensuring transparency: presenting the trade-offs between the research treatment options.

Am J Bioeth. 2013;13(12):50-2. doi: 10.1080/15265161.2013.852272.

What should be disclosed to research participants?

Am J Bioeth. 2013;13(12):3-8. doi: 10.1080/15265161.2013.851578.

Randomization and the transactional framework for informed consent.

Am J Bioeth. 2009 Feb;9(2):16-7. doi: 10.1080/15265160802666297.

Randomization can be risky.

Am J Bioeth. 2009 Feb;9(2):17-8. doi: 10.1080/15265160802668954.

Understanding randomization: helpful strategies.

Am J Bioeth. 2009 Feb;9(2):14-5. doi: 10.1080/15265160802663245.

引用本文的文献

When a Patient Is at Foreseeable Risk of Losing Decisional and Functional Capacity.

J Am Acad Psychiatry Law. 2024 Dec 12;52(4):414-424. doi: 10.29158/JAAPL.240070-24.

Ethics of drug studies in the newborn.

Paediatr Drugs. 2015 Feb;17(1):37-42. doi: 10.1007/s40272-014-0099-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

What are reasonably foreseeable risks?

Am J Bioeth. 2013;13(12):29-30. doi: 10.1080/15265161.2013.849304.

The weird divergence of ethics and regulation with regard to informed consent.

Am J Bioeth. 2013;13(12):31-3. doi: 10.1080/15265161.2013.849308.

Randomization should be disclosed to potential research subjects.

Am J Bioeth. 2013;13(12):35-7. doi: 10.1080/15265161.2013.849307.

Risk, respect for persons, and informed consent in comparative effectiveness research.

Am J Bioeth. 2013;13(12):46-8. doi: 10.1080/15265161.2013.851299.

The "research misconception" and the SUPPORT trial: toward evidence-based consensus.

Am J Bioeth. 2013;13(12):48-50. doi: 10.1080/15265161.2013.851297.

Ensuring transparency: presenting the trade-offs between the research treatment options.

Am J Bioeth. 2013;13(12):50-2. doi: 10.1080/15265161.2013.852272.

What should be disclosed to research participants?

Am J Bioeth. 2013;13(12):3-8. doi: 10.1080/15265161.2013.851578.

Randomization and the transactional framework for informed consent.

Am J Bioeth. 2009 Feb;9(2):16-7. doi: 10.1080/15265160802666297.

Randomization can be risky.

Am J Bioeth. 2009 Feb;9(2):17-8. doi: 10.1080/15265160802668954.

Understanding randomization: helpful strategies.

Am J Bioeth. 2009 Feb;9(2):14-5. doi: 10.1080/15265160802663245.

引用本文的文献

When a Patient Is at Foreseeable Risk of Losing Decisional and Functional Capacity.

J Am Acad Psychiatry Law. 2024 Dec 12;52(4):414-424. doi: 10.29158/JAAPL.240070-24.

Ethics of drug studies in the newborn.

Paediatr Drugs. 2015 Feb;17(1):37-42. doi: 10.1007/s40272-014-0099-8.